Aptahem AB (XSAT:APTA) Total Tax Payable : kr0.00 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB Total Tax Payable?

Aptahem AB's Total Tax Payable for the quarter that ended in Sep. 2024 was kr0.00 Mil.

Aptahem AB's annual Total Tax Payable increased from Dec. 2021 (kr0.02 Mil) to Dec. 2022 (kr0.08 Mil) and increased from Dec. 2022 (kr0.08 Mil) to Dec. 2023 (kr0.08 Mil).

Aptahem AB Total Tax Payable Historical Data

The historical data trend for Aptahem AB's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB Total Tax Payable Chart

Aptahem AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

0.01

0.02

0.08

Aptahem AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															-	0.08	-	-	-

Aptahem AB Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Aptahem AB Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Aptahem AB's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norra Vallgatan 58, Malmo, SWE, 211 22

Website

http://www.aptahem.com

Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB Headlines

No Headlines